-
Stock availabilitIn Stock
In Stock
-
CAS number
6318-41-8
-
Description
PI 3-Kgamma kinase inhibitor
-
Molecular weight
249,2 g/mol
-
Primary research fields
Cell Signaling, Cancer, Apoptosis, Cancer Growth Inhibitors, Tyrosine Kinase Inhibitors
-
Other name
NSC31098, 5-Benzo[1,3]dioxol-5-ylmethylene-thiazolidine-2,4-dione
-
Product category
Small Molecules
-
Product type
Inhibitor
-
Chemical formula
C11H7NO4S
-
Origin
Synthetic
-
Purity pourcentage
≥98% (TLC)
-
Soluble in
Soluble in DMSO (25 mg/ml). For in vivo administration this compound was suspended in 0.5% carboxymethylcellulose/0.25% Tween 20 as a vehicle
-
Physical appearance
Yellow solid
-
Storage recommendations
-20ºC
-
Shipping recommendations
Shipped Ambient
-
Safety information
Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
-
PubChem number
233033
-
Scientific context
AS 041164 is a selective PI 3-Kγ isoform inhibitor. It also blocks neutrophil migration.
-
Bibliography
1. Ferrandi C., et al. (2007) J. Pharmacol. Exp.Ther. 322(3): 923–930.
-
Release date
1-Oct-2014
-
PubMed number
Refer to PubMed
-
Tested applications
To be tested
-
Tested reactivity
To be tested
-
-
Representative figure legend
Chemical structure of AS 041164 (SIH-433), a PI 3-Kgamma kinase inhibitor. CAS #: 6318-41-8. Molecular Formula: C11H7NO4S. Molecular Weight: 249.2 g/mol. Chemical structure of AS 041164 , a PI 3-Kgamma kinase inhibitor (SIH-433). CAS # 6318-41-8. Molecular Formula: C11H7NO4S.
-
Warning information
Non-hazardous
-
Country of production
Canada
-
Total weight kg
0.25
-
Net weight g
0.05
-
-
Additional description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.